Journal article
Columba de la Parra, Ailed M Cruz-Collazo, L. Castillo‐Pichardo, L. Cubano, R. Redis, G. Calin, S. Dharmawardhane
2015
2015
Semantic Scholar
DOI
Cite
Cite
APA
Click to copy
de la Parra, C., Cruz-Collazo, A. M., Castillo‐Pichardo, L., Cubano, L., Redis, R., Calin, G., & Dharmawardhane, S. (2015). Downregulation of miR‐155 Contributes to The Anti‐proliferative Effects of The Soy Isoflavone Genistein in Estrogen Receptor Negative Breast Cancer.
Chicago/Turabian
Click to copy
Parra, Columba de la, Ailed M Cruz-Collazo, L. Castillo‐Pichardo, L. Cubano, R. Redis, G. Calin, and S. Dharmawardhane. “Downregulation of MiR‐155 Contributes to The Anti‐Proliferative Effects of The Soy Isoflavone Genistein in Estrogen Receptor Negative Breast Cancer” (2015).
MLA
Click to copy
de la Parra, Columba, et al. Downregulation of MiR‐155 Contributes to The Anti‐Proliferative Effects of The Soy Isoflavone Genistein in Estrogen Receptor Negative Breast Cancer. 2015.
BibTeX Click to copy
@article{columba2015a,
title = {Downregulation of miR‐155 Contributes to The Anti‐proliferative Effects of The Soy Isoflavone Genistein in Estrogen Receptor Negative Breast Cancer},
year = {2015},
author = {de la Parra, Columba and Cruz-Collazo, Ailed M and Castillo‐Pichardo, L. and Cubano, L. and Redis, R. and Calin, G. and Dharmawardhane, S.}
}
Abstract
Consumption of the soy isoflavone genistein has been associated with reduced breast cancer risk. We previously reported that dietary genistein inhibits mammary tumor growth and metastasis of estrogen receptor (ER) (‐) cancer cells in mice. The objective of this study was to investigate a role for the oncomir miR‐155 in the anticancer effects of genistein. At low physiologically relevant concentrations, genistein inhibited cell viability, induced apoptosis, and downregulated miR‐155 in the ER (‐) MDA‐MB‐435 and Hs578t breast cancer cells, without significantly affecting the viability or miR‐155 levels of ER (+) MCF‐7 breast cancer cells. In parallel, the pro‐apoptotic and anti‐cell proliferative miR‐155 targets FOXO3, PTEN, casein kinase, and p27 were upregulated in response to genistein in the ER (‐) cells. Ectopic expression of miR‐155 in the MDA‐MB‐435 and Hs578t cells decreased the effects of genistein on cell viability, and abrogated the effects of genistein on apoptosis and expression of pro‐apoptotic genes. We conclude that genistein‐mediated downregulation of miR‐155, a critical suppressor of apoptosis, contributes to the anticancer effects of genistein in ER (‐) breast cancer.
